Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Evolve Telemed vs NextMeds

Evolve Telemed
Graded #379

Lower grade

vs+8.199999999999996
NextMeds
Graded #191

Higher grade

The verdict

NextMeds takes it — 66.3/100 to 58.1/100.

NextMeds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. NextMeds is a cash-pay telehealth platform offering compounded semaglutide and compounded tirzepatide on a flat monthly membership — one price bundling the medication (if prescribed), telehealth visits, a…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueNextMeds +11
45
56
Dose & formulationNextMeds +11
53
64
Clinical oversightEvolve Telemed +6
83
77
Labs & monitoringNextMeds +9
52
61
FulfillmentNextMeds +22
62
84
Contract termsNextMeds +6
55
61
Evolve Telemed · left barNextMeds · right bar

The numbers

MetricEvolve TelemedNextMeds
WeighScore58.1/10066.3/100
GradeCC
Scorecard rank#379#191
SemaglutideNot disclosed$129/mo (plus a separate fee, compounded)
TirzepatideNot disclosed$179/mo (plus a separate fee, compounded)
CoverageCoverage not publishedAll 50 states
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
Evolve Telemed

Graded #379 · C

Strengths

  • Established hormone- and peptide-optimization brand with board-certified specialists and a physician-plus-care-specialist support model
  • Compounded GLP-1 (semaglutide) weight care offered alongside TRT, menopause/BHRT, thyroid and sexual-wellness programs in one practice
  • Coordinated couples care plans plus dedicated men's and women's tracks
  • Free consultation to start, with published press, blog and FAQ resources

Where it loses points

  • No GLP-1 pricing published — cost is only revealed after a consultation, so you can't compare value upfront
  • Doesn't list the states it serves or name its compounding pharmacies
  • Weight loss is one of many verticals, not a dedicated GLP-1-first program
  • Tirzepatide availability isn't confirmed on the site; only compounded semaglutide is referenced
  • Not shown on our price-ranked /best lists because no pricing is disclosed
NextMeds

Graded #191 · C

Strengths

  • Flat monthly membership bundles the medication, telehealth visits, a 1:1 care coach and a licensed registered dietitian — one price, no hidden fees
  • Same price every dose, no auto-renewal, cancel anytime; free shipping and no insurance needed (FSA eligible)
  • Names a compounding pharmacy partner (Foothills Pharmacy) and states it services all 50 states
  • Free, no-obligation online assessment before you pay anything

Where it loses points

  • Shows a LegitScript 'approval' but links only a generic directory search, not a verifiable seal — we couldn't independently confirm it
  • Promo-driven pricing with a countdown timer and 'price increases' urgency; the standing membership is $129 (sema) / $179 (tirz)
  • A technology platform that coordinates care, not the medical provider; individual clinicians and a medical director aren't named on the site
  • Compounded semaglutide and tirzepatide only — no brand-name (Wegovy/Zepbound) options
  • Compounded GLP-1s are not FDA-reviewed or approved — a different evidence and regulatory tier than brand-name

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard